Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Por um escritor misterioso

Last updated 12 abril 2025

The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open

PDF) Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study

Full article: Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

Brexpiprazole: A New Treatment Option for Schizophrenia - Innovations in Clinical Neuroscience

Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study

Full article: Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

Brexpiprazole-impurities

Journal Digest: Z-Drugs and Dementia; Methotrexate and Schizophrenia; Smartphones and Depression; Brexpiprazole and Sexual Function; E-Cigarettes and Youth; Opioids Deaths and Neighborhoods

Aripiprazole, brexpiprazole, and cariprazine: Not all the same

Recomendado para você